Clinical Trial: Carotegrast Methyl in Ulcerative Colitis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Ulcerative Colitis
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of Carotegrast Methyl in Active Ulcerative Colitis: a Real-World Prospective Cohort Study
Brief Summary:
Carotegrast methyl, an oral ?4-integrin inhibitor, was recently approved in Japan for the treatment of active ulcerative colitis (UC).However, real-world data regarding its efficacy and safety remain scarce.This study aimed to assess the clinical effectiveness and safety profile of carotegrast methyl in patients with active UC.
Read more